… any alteration in prostate cancer risk for men treated in a clinical … done in the largest prospective
population-based cohort of men … patterns, PSA levels, and prostate cancer diagnostics. …

… their safety on prostate cancer incidence, we conducted a large population-based study to …
-ARIs for BPH to treat initial symptoms of yet undiagnosed prostate cancer, and to account for …

… This large population-based cohort study found a decreased risk of death of prostate cancer
in men treated with 5-ARI for more than 2 years for lower urinary tract symptoms compared …

… 5-ARI use and high grade prostate cancer. The aim of … treating lower urinary tract symptoms
due to prostatic enlargement in a clinical setting and prostate cancer risk, in particular cancer …

… In this large population-based study, we observed that prediagnostic users of 5-ARIs … that
5-ARIs inherently increase the risk of high-grade prostate cancer as suggested by the US Food …

… treatment effect, a requirement for a time period of >2 years (based on our results), and potential
… concerns due to the black-box warning that persists regarding high-risk prostate cancer. …

… A history of testicular cancer, prostate cancer and treatment with … large study population,
there was no evidence that men treated with 5α-reductase inhibitors are at an increased risk …

… The 5α-reductase inhibitors finasteride and dutasteride are used to treat lower urinary tract
… Similar findings were observed in a large population based Finnish observational study …

… -inhibitors (5-ARIs) are approved for treating benign prostatic hyperplasia (BPH) and have
been found to reduce prostate cancer (PCa) risk … of the largest, population-based cohorts with …

… 5αRIs inhibit the 5α-reductase enzyme, resulting in lower levels of … In our large
population-based cohort study, we did not … adjusted for cancers other than prostate cancer and …